MARKET

AZN

AZN

AstraZeneca
NYSE
184.45
+0.07
+0.04%
After Hours: 185.01 +0.56 +0.30% 19:58 11/13 EST
OPEN
184.77
PREV CLOSE
184.38
HIGH
186.15
LOW
183.93
VOLUME
1.85M
TURNOVER
--
52 WEEK HIGH
209.11
52 WEEK LOW
152.66
MARKET CAP
286.09B
P/E (TTM)
26.10
1D
5D
1M
3M
1Y
5Y
1D
Cigarette Sales Keep Falling. These 2 Tobacco Stocks Still Pay 5.5% Dividends
24/7 Wall St. · 13h ago
AstraZeneca Gets FDA Approval for Bladder Cancer Treatment
Dow Jones · 1d ago
AstraZeneca announces FDA approval of imfinzi/EV combination
TipRanks · 1d ago
AstraZeneca gains additional bladder cancer indication for Imfinzi
Seeking Alpha · 1d ago
AstraZeneca eliminates 600 respiratory and immunology sales reps: Bloomberg
Seeking Alpha · 1d ago
AstraZeneca’s Alexion receives FDA approval for Klygefa
TipRanks · 1d ago
FDA approves AstraZeneca combo treatment for bladder cancer
TipRanks · 1d ago
Perioperative IMFINZI® (durvalumab) approved in the US in novel regimen with neoadjuvant enfortumab vedotin-ejfv for patients with muscle-invasive bladder cancer
Barchart · 1d ago
More
About AZN
AstraZeneca PLC is a United Kingdom-based science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines. The Company operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. It has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The Company distributes its products in over 125 countries.

Webull offers AstraZeneca PLC (US) stock information, including NYSE: AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.